Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 Diabetes: Response to Genuth, Lachin, and Nathan

Diabetes Care - United States
doi 10.2337/diacare.28.1.234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 Diabetes: Response to McCarter Et Al.

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2004English

HbA1c Variability and the Risk of Microalbuminuria in Patients With Type 1 Diabetes

International Journal of Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2015English

G235(P) Hba1c Control in Type 1 Diabetes With Retinopathy, a Reassessment at 5 Years

2018English

Variation of Glycosylated Hemoglobin (HbA1C) Cutoff Among Type-2 Diabetic Nephropathy Patients

Journal of Endocrinology and Diabetes
2018English

Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2003English

Association of Diabetic Retinopathy in Type II Diabetes Mellitus With Hba1c Levels: A Study

IOSR Journal of Dental and Medical Sciences
2016English

Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2019English

The Response of Antioxidant Genes to Hyperglycemia Is Abnormal in Patients With Type 1 Diabetes and Diabetic Nephropathy

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Differences in the Risk Factors Associated With Diabetic Retinopathy Between Type 1 and Type 2 Diabetes Mellitus

Endocrine Abstracts
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy